PDT Partners’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-37,460
| Closed | -$755K | – | 1073 |
|
|
2021
Q3 | $755K | Buy |
+37,460
| New | +$755K | 0.05% | 398 |
|
|
2021
Q1 | – | Sell |
-19,905
| Closed | -$439K | – | 937 |
|
|
2020
Q4 | $439K | Buy |
+19,905
| New | +$439K | 0.03% | 472 |
|
|
2020
Q1 | – | Sell |
-9,688
| Closed | -$213K | – | 910 |
|
|
2019
Q4 | $213K | Buy |
+9,688
| New | +$213K | 0.01% | 633 |
|
|
2017
Q2 | – | Sell |
-25,300
| Closed | -$86K | – | 592 |
|
|
2017
Q1 | $86K | Sell |
25,300
-4,000
| -14% | -$13.6K | ﹤0.01% | 463 |
|
|
2016
Q4 | $84K | Buy |
29,300
+4,100
| +16% | +$11.8K | 0.01% | 491 |
|
|
2016
Q3 | $148K | Buy |
+25,200
| New | +$148K | 0.01% | 451 |
|
|
2016
Q1 | – | Sell |
-19,833
| Closed | -$235K | – | 612 |
|
|
2015
Q4 | $235K | Sell |
19,833
-23,722
| -54% | -$281K | 0.03% | 336 |
|
|
2015
Q3 | $358K | Sell |
43,555
-14,019
| -24% | -$115K | 0.01% | 1005 |
|
|
2015
Q2 | $803K | Buy |
57,574
+44,274
| +333% | +$618K | 0.02% | 805 |
|
|
2015
Q1 | $320K | Buy |
+13,300
| New | +$320K | 0.01% | 1139 |
|